To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C4orf34TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
429 supporting clones for gene C4orf34 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CA942037 Pancreas, Purified pancreatic islet C4orf34.a 1 to 538 1 to 538 exact tiling clone, fully sequenced,   538/538
(100 %)
0 diff
(100 %id)
CD709679 normal nasopharynx C4orf34.a 30 to 398 1 to 374       374/374
(100 %)
12 diff
(96.8 %id)
BG678573 skin, squamous cell carcinoma C4orf34.a 40 to 830 1 to 791       791/791
(100 %)
10 diff
(98.8 %id)
BE568297 bladder, carcinoma, cell line C4orf34.a 48 to 656 1 to 604       604/609
(99 %)
8 diff
(98.7 %id)
CA952854 Pancreas, Purified pancreatic islet C4orf34.a 508 to 1053 546 to 1   tiling clone, fully sequenced,   546/546
(100 %)
0 diff
(100 %id)
DA812571 ovary, tumor tissue C4orf34.b 1 to 667 2 to 664 F68S L69Y L70* tiling clone, capped   663/663
(100 %)
5 diff
(99.3 %id)
DB371985 ovary, tumor tissue C4orf34.b 1267 to 1841 575 to 1   tiling clone,   575/575
(100 %)
19 diff
(96.7 %id)
BE244840 leukopheresis C4orf34.c 1 to 360 1 to 361   tiling clone,   361/361
(100 %)
5 diff
(98.7 %id)
CD684215 normal nasopharynx C4orf34.c 10 to 566 27 to 583 exact     557/583
(95 %)
6 diff
(99.0 %id)
CD688073 normal nasopharynx C4orf34.c 10 to 586 16 to 592 exact     577/592
(97 %)
6 diff
(99.0 %id)
CD693248 normal nasopharynx C4orf34.c 10 to 586 16 to 592 exact     577/592
(97 %)
8 diff
(98.7 %id)
BE244395 leukopheresis C4orf34.c 13 to 360 1 to 348       348/348
(100 %)
2 diff
(99.5 %id)
BG531471 embryonal carcinoma, testis C4orf34.c 16 to 651 1 to 638 exact     638/889
(71 %)
22 diff
(97.6 %id)
CD706935 normal nasopharynx C4orf34.c 17 to 386 18 to 387       370/387
(95 %)
6 diff
(98.5 %id)
BF794352 lymph, lymphoma, cell line C4orf34.c 30 to 741 1 to 706 exact     706/1007
(70 %)
16 diff
(98.5 %id)
BG024768 lymph, lymphoma, cell line C4orf34.c 30 to 608 29 to 616 F68C     588/1058
(55 %)
21 diff
(98.1 %id)
BF794472 lymph, lymphoma, cell line C4orf34.c 33 to 719 1 to 689 exact     689/1098
(62 %)
4 diff
(99.7 %id)
BG106149 lymph, lymphoma, cell line C4orf34.c 41 to 819 1 to 790 exact     790/1123
(70 %)
35 diff
(96.9 %id)
BM477252 lymph, lymphoma, cell line C4orf34.c 41 to 1063 1 to 1034 exact tiling clone,   1034/1116
(92 %)
53 diff
(95.3 %id)
BQ063087 lymph, lymphoma, cell line C4orf34.c 45 to 720 1 to 677 F6S     677/1040
(65 %)
5 diff
(99.6 %id)
BQ049060 lymph, lymphoma, cell line C4orf34.c 50 to 967 1 to 925 exact tiling clone,   925/990
(93 %)
15 diff
(98.5 %id)
BM477241 lymph, lymphoma, cell line C4orf34.c 52 to 967 1 to 921 exact tiling clone,   921/1124
(81 %)
14 diff
(98.8 %id)
TI_154185664   C4orf34.c 133 to 862 116 to 836 exact tiling clone,   721/928
(77 %)
17 diff
(98.2 %id)
BQ888964 dorsal root ganglia C4orf34.d 1 to 893 1 to 905   tiling clone,   905/916
(98 %)
14 diff
(98.5 %id)
TI_57197125   C4orf34.d 90 to 879 29 to 831 C11L V12C C13L S14L H15S ...     801/831
(96 %)
31 diff
(96.3 %id)
BI820939 pooled brain, lung, testis C4orf34.d 94 to 801 1 to 715 C11L V12C C13L S14L H15S ...     713/799
(89 %)
23 diff
(97.2 %id)
BX365496   C4orf34.d 98 to 923 1 to 827       827/827
(100 %)
3 diff
(99.7 %id)
CV572289 cornea, eye C4orf34.d 106 to 746 1 to 641       641/641
(100 %)
0 diff
(100 %id)
BG703190 brain, hippocampus C4orf34.d 125 to 807 1 to 682       682/682
(100 %)
7 diff
(99.0 %id)
BG428690 Kidney C4orf34.d 129 to 724 1 to 596 F6L D7I C9V E10N C11V ...     596/763
(78 %)
16 diff
(98.0 %id)
DA677298   C4orf34.d 130 to 723 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
BM838221 Ascites, stomach C4orf34.d 130 to 686 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
DA992362 synovial membrane tissue from rheumatioidarthritis C4orf34.d 130 to 681 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB289348 uterus C4orf34.d 130 to 694 2 to 567 C9* capped   566/566
(100 %)
3 diff
(99.5 %id)
DA421277 cervix C4orf34.d 157 to 723 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
FN123361 breast carcinoma C4orf34.d 162 to 241 83 to 4     Submitted on the opposite strand 80/85
(94 %)
0 diff
(100 %id)
DC352129 brain C4orf34.d 167 to 440 1 to 274       274/274
(100 %)
2 diff
(99.3 %id)
BY795744 eye C4orf34.d 171 to 570 1 to 400       400/400
(100 %)
0 diff
(100 %id)
DB448629 testis C4orf34.d 175 to 598 1 to 426       426/426
(100 %)
3 diff
(99.3 %id)
DR422024 eye, Pterygium C4orf34.d 178 to 957 1 to 778 Q40H     778/778
(100 %)
11 diff
(98.6 %id)
BG494045 lung, mucoepidermoid carcinoma C4orf34.d 183 to 941 1 to 773 P84A T85N S86Q P87S H88S ...     773/780
(99 %)
24 diff
(97.0 %id)
BX417540 placenta C4orf34.d 191 to 1201 1 to 996 L26Y R27G Q28S S29P Q30S ...     996/1002
(99 %)
22 diff
(97.9 %id)
DA512038 brain C4orf34.d 195 to 754 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA541686 lung C4orf34.d 195 to 781 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA869874 Prostate C4orf34.d 195 to 675 2 to 483   capped   482/482
(100 %)
1 diff
(99.8 %id)
BM310798 Pancreas, Purified pancreatic islet C4orf34.d 198 to 781 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA131595 alzheimer cortex C4orf34.d 198 to 776 2 to 581 G50S capped   580/580
(100 %)
3 diff
(99.5 %id)
DN912184   C4orf34.d 198 to 462 1 to 265       265/282
(93 %)
5 diff
(98.3 %id)
CA776616 Pancreas, Purified pancreatic islet C4orf34.d 198 to 785 1 to 588       588/588
(100 %)
0 diff
(100 %id)
DA727280   C4orf34.d 199 to 768 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AI929453 brain, frontal lobe C4orf34.d 201 to 692 1 to 492 C11W     492/492
(100 %)
1 diff
(99.8 %id)
BX331521 Neuroblastoma Cot 10-normalized C4orf34.d 203 to 969 1 to 767       767/767
(100 %)
0 diff
(100 %id)
DA554305   C4orf34.d 205 to 778 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
TI_57173611   C4orf34.d 207 to 990 64 to 846       783/846
(92 %)
11 diff
(98.7 %id)
CB069485 Pancreas, Purified pancreatic islet C4orf34.d 210 to 752 10 to 552 H88Y     543/552
(98 %)
7 diff
(98.8 %id)
BI826410 brain, medulla C4orf34.d 211 to 990 1 to 779       779/779
(100 %)
5 diff
(99.4 %id)
BQ440384 leiomyosarcoma, uterus C4orf34.d 212 to 1070 1 to 864       864/864
(100 %)
8 diff
(99.1 %id)
TI_57149657   C4orf34.d 212 to 1011 32 to 828       797/829
(96 %)
17 diff
(98.0 %id)
BE974157 Prostate C4orf34.d 213 to 700 1 to 488 C13A S14L H15M E16N H17M ...     488/488
(100 %)
2 diff
(99.6 %id)
BM504858 Pancreas, Purified pancreatic islet C4orf34.d 214 to 804 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
BG899428 cartilage C4orf34.d 216 to 568 86 to 438       353/370
(95 %)
6 diff
(98.4 %id)
CN483776 eye C4orf34.d 216 to 775 1 to 563       563/563
(100 %)
8 diff
(98.6 %id)
BI759636 pooled colon, kidney, stomach C4orf34.d 216 to 1011 1 to 792       792/793
(99 %)
10 diff
(98.8 %id)
CN366569 embryonic stem cells, DMSO-treated H9 cellline C4orf34.d 220 to 881 1 to 662       662/662
(100 %)
0 diff
(100 %id)
CD686050 normal nasopharynx C4orf34.d 223 to 609 20 to 406       387/406
(95 %)
7 diff
(98.3 %id)
CD690913 normal nasopharynx C4orf34.d 223 to 773 15 to 565 F68Y     551/565
(97 %)
7 diff
(98.8 %id)
CD692591 normal nasopharynx C4orf34.d 223 to 685 29 to 491       463/491
(94 %)
11 diff
(97.8 %id)
CD698450 normal nasopharynx C4orf34.d 223 to 529 20 to 326       307/326
(94 %)
6 diff
(98.2 %id)
CD699440 normal nasopharynx C4orf34.d 223 to 530 40 to 346       307/346
(88 %)
7 diff
(98.0 %id)
CD707278 normal nasopharynx C4orf34.d 223 to 545 20 to 343       324/343
(94 %)
7 diff
(98.0 %id)
CD709540 normal nasopharynx C4orf34.d 223 to 563 34 to 377       344/377
(91 %)
7 diff
(98.2 %id)
BU561373 testis C4orf34.d 223 to 869 1 to 653       653/824
(79 %)
11 diff
(98.7 %id)
CD703198 normal nasopharynx C4orf34.d 225 to 843 17 to 635       619/635
(97 %)
8 diff
(98.8 %id)
CD707622 normal nasopharynx C4orf34.d 225 to 655 10 to 439       430/441
(97 %)
8 diff
(98.2 %id)
BF185249 bone marrow, from chronic myelogenous leukemia C4orf34.d 225 to 974 1 to 737 C13A S14L H15M E16N H17M ...     737/833
(88 %)
33 diff
(96.1 %id)
BG529854 embryonal carcinoma, testis C4orf34.d 225 to 1061 1 to 843       843/905
(93 %)
27 diff
(97.1 %id)
AL711064 human skeletal muscle C4orf34.d 226 to 679 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BF696152 brain, primitive neuroectoderm C4orf34.d 227 to 811 1 to 606 C9L E10*     606/853
(71 %)
43 diff
(95.0 %id)
BF977889 melanotic melanoma, high MDR, skin C4orf34.d 228 to 913 1 to 702 G47V D48I N49M G50A I51S ...     702/806
(87 %)
39 diff
(95.2 %id)
BF679595 Prostate C4orf34.d 229 to 809 1 to 577 R71E P72T P73S N74*     577/889
(64 %)
16 diff
(98.3 %id)
BG541917 lung C4orf34.d 229 to 1035 1 to 804 S31Y S46L G47V D48I N49M ...     804/814
(98 %)
39 diff
(95.3 %id)
BG542360 lung C4orf34.d 229 to 850 1 to 626 C13G F68S R71E P72T P73S ...     626/626
(100 %)
22 diff
(96.5 %id)
BG542691 lung C4orf34.d 229 to 907 1 to 686       686/688
(99 %)
18 diff
(97.4 %id)
DN990518 brain, whole brain C4orf34.d 229 to 827 9 to 607       599/607
(98 %)
6 diff
(99.1 %id)
AK023351 ovary, tumor tissue C4orf34.d 230 to 1885 1 to 1656   tiling clone, available from FLJ,   1656/1656
(100 %)
0 diff
(100 %id)
BC008502 Prostate C4orf34.d 230 to 1883 1 to 1654   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1654/1656
(99 %)
2 diff
(99.9 %id)
NM_174921.1   C4orf34.d 230 to 1885 1 to 1656   RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1656/1656
(100 %)
2 diff
(99.9 %id)
DB225214 trachea C4orf34.d 230 to 811 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
AV648974 corresponding non cancerous liver tissue C4orf34.d 231 to 913 1 to 683 Q91X   Submitted on the opposite strand 683/692
(98 %)
11 diff
(98.5 %id)
DA725108   C4orf34.d 231 to 787 10 to 567   capped   558/558
(100 %)
2 diff
(99.7 %id)
AU134047 ovary, tumor tissue C4orf34.d 231 to 956 2 to 734 C33X I51X capped   733/741
(98 %)
13 diff
(98.3 %id)
DA914441   C4orf34.d 231 to 782 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA976993 synovial membrane tissue from rheumatioidarthritis C4orf34.d 231 to 805 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA992987 synovial membrane tissue from rheumatioidarthritis C4orf34.d 231 to 807 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AV722186 hypothalamus C4orf34.d 232 to 660 1 to 421       421/421
(100 %)
13 diff
(97.0 %id)
BE788003 large cell carcinoma, lung C4orf34.d 232 to 785 1 to 554       554/921
(60 %)
10 diff
(99.0 %id)
BM839098 Ascites, stomach C4orf34.d 232 to 748 1 to 517       517/517
(100 %)
1 diff
(99.9 %id)
DA316406 hippocampus C4orf34.d 233 to 789 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
U46278 liver cell line, pancreatic cancer C4orf34.d 233 to 558 1 to 326       326/326
(100 %)
2 diff
(99.4 %id)
CD701843 normal nasopharynx C4orf34.d 236 to 722 29 to 515       487/515
(94 %)
7 diff
(98.7 %id)
BG534242 lung C4orf34.d 238 to 997 1 to 765 D99G *100L     765/768
(99 %)
18 diff
(97.7 %id)
CX870194 embryonic stem C4orf34.d 239 to 1015 1 to 777       777/777
(100 %)
0 diff
(100 %id)
BG656212 Pancreas, Purified pancreatic islet C4orf34.d 240 to 795 1 to 556 H88Y     556/556
(100 %)
4 diff
(99.3 %id)
BF382682 brain, primitive neuroectoderm C4orf34.d 241 to 891 1 to 656 L75S R76K G77R S78I S79Q ...     656/869
(75 %)
22 diff
(97.5 %id)
ES312991 beard hair, skin C4orf34.d 242 to 415 1 to 174       174/174
(100 %)
0 diff
(100 %id)
CN366572 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 C4orf34.d 243 to 638 1 to 396       396/396
(100 %)
7 diff
(98.3 %id)
AV702016 adrenal gland C4orf34.d 244 to 916 1 to 673 V12A     673/704
(95 %)
20 diff
(97.2 %id)
BE564308 bladder, carcinoma, cell line C4orf34.d 245 to 773 1 to 535 F68S G90W Q91T D92R P93S ...     535/750
(71 %)
12 diff
(98.4 %id)
BE565050 bladder, carcinoma, cell line C4orf34.d 245 to 988 1 to 752 C13V S14L H15S E16*     752/806
(93 %)
61 diff
(92.5 %id)
BF030990 hypernephroma, Kidney C4orf34.d 245 to 839 1 to 583 S86V P87L H88I N89M G90D ...     583/874
(66 %)
14 diff
(98.4 %id)
BE970230 Pancreas C4orf34.d 245 to 832 1 to 585       585/585
(100 %)
5 diff
(99.2 %id)
BF028397 bladder, carcinoma, cell line C4orf34.d 245 to 934 1 to 681 C13A S14L H15M E16N H17M ...     681/809
(84 %)
16 diff
(98.1 %id)
BM837958 Ascites, stomach C4orf34.d 245 to 879 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BE865745 bladder, carcinoma, cell line C4orf34.d 248 to 933 1 to 681 F6L D7I C9V E10N C11V ...     681/836
(81 %)
27 diff
(96.8 %id)
BF131587 hypernephroma, Kidney C4orf34.d 249 to 809 1 to 557 C13A S14L H15M E16N H17M ...     557/557
(100 %)
6 diff
(99.0 %id)
CN366570 embryonic stem cells, cell lines H1, H7, andH9 C4orf34.d 250 to 908 1 to 659       659/659
(100 %)
1 diff
(99.9 %id)
BM544748 brain, hippocampus C4orf34.d 252 to 1247 1 to 1013       1013/1056
(95 %)
12 diff
(98.9 %id)
BU507264 leiomyosarcoma, uterus C4orf34.d 253 to 1057 1 to 812       812/863
(94 %)
17 diff
(98.1 %id)
CK822411 Pancreas, Purified pancreatic islet C4orf34.d 255 to 847 1 to 592     Submitted on the opposite strand 592/592
(100 %)
1 diff
(99.9 %id)
BF030291 hypernephroma, Kidney C4orf34.d 261 to 947 1 to 676 C13A S14L H15M E16N H17M ...     676/731
(92 %)
45 diff
(93.9 %id)
BP419519 small intestine C4orf34.d 279 to 776 1 to 498     Submitted on the opposite strand 498/498
(100 %)
0 diff
(100 %id)
AA347293 heart C4orf34.d 297 to 670 1 to 374       374/374
(100 %)
3 diff
(99.2 %id)
AA369574 placenta C4orf34.d 302 to 530 1 to 230       230/230
(100 %)
3 diff
(98.7 %id)
BF974739 B-cells, primary B-cells from tonsils (cell line) C4orf34.d 361 to 1118 1 to 758       758/761
(99 %)
18 diff
(97.7 %id)
DA554769   C4orf34.d 368 to 918 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
CN366571 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells C4orf34.d 369 to 739 1 to 371       371/371
(100 %)
0 diff
(100 %id)
BE380039 bladder, carcinoma, cell line C4orf34.d 373 to 1001 1 to 624 M19*     624/624
(100 %)
9 diff
(98.6 %id)
BF675860 Prostate C4orf34.d 374 to 1112 1 to 730 G47V D48I N49M G50A I51S ...     730/767
(95 %)
28 diff
(96.4 %id)
CV027442 mixed C4orf34.d 388 to 686 1 to 299       299/500
(59 %)
1 diff
(99.8 %id)
AA813287   C4orf34.d 426 to 837 415 to 4       412/415
(99 %)
0 diff
(100 %id)
BG503916 embryonal carcinoma, testis C4orf34.d 429 to 1171 1 to 736       736/736
(100 %)
10 diff
(98.7 %id)
AW895933 nervous_normal C4orf34.d 456 to 856 26 to 424       406/424
(95 %)
6 diff
(98.6 %id)
AW895672 nervous_normal C4orf34.d 474 to 939 1 to 465       465/467
(99 %)
3 diff
(99.4 %id)
AW895666 nervous_normal C4orf34.d 487 to 952 1 to 466       466/466
(100 %)
9 diff
(98.1 %id)
BG566539 Liver C4orf34.d 489 to 1237 1 to 750       750/1004
(74 %)
33 diff
(96.8 %id)
BF700088 brain, primitive neuroectoderm C4orf34.d 498 to 1234 1 to 720       720/745
(96 %)
29 diff
(96.2 %id)
BQ277515 mixed (pool of 40 RNAs) C4orf34.d 510 to 1351 1 to 854       854/878
(97 %)
19 diff
(97.9 %id)
EC567294 Prostate C4orf34.d 512 to 562 53 to 3       51/58
(87 %)
0 diff
(100 %id)
BG183516   C4orf34.d 514 to 1377 864 to 14     Submitted on the opposite strand 851/876
(97 %)
22 diff
(97.5 %id)
BG776081 lung, mucoepidermoid carcinoma C4orf34.d 516 to 1140 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
FN110955 breast carcinoma C4orf34.d 521 to 587 68 to 1     Submitted on the opposite strand 68/90
(75 %)
2 diff
(97.8 %id)
BG190878   C4orf34.d 530 to 1383 860 to 8     Submitted on the opposite strand 853/861
(99 %)
12 diff
(98.7 %id)
FN055876 breast carcinoma C4orf34.d 530 to 595 1 to 66       66/66
(100 %)
3 diff
(95.5 %id)
BG540357 lung C4orf34.d 544 to 1337 1 to 789       789/790
(99 %)
15 diff
(98.2 %id)
FN106507 breast carcinoma C4orf34.d 550 to 604 1 to 55       55/59
(93 %)
1 diff
(98.4 %id)
DW451964 Liver C4orf34.d 552 to 909 17 to 373       357/373
(95 %)
12 diff
(96.8 %id)
DA238502 brain C4orf34.d 556 to 1105 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
CD108795 brain, Pituitary C4orf34.d 556 to 1062 1 to 507   AAA   507/604
(83 %)
5 diff
(99.2 %id)
AW895863 nervous_normal C4orf34.d 569 to 938 368 to 1       368/368
(100 %)
1 diff
(99.8 %id)
BG535866 lung C4orf34.d 570 to 1134 1 to 557       557/698
(79 %)
32 diff
(95.5 %id)
FN077083 breast carcinoma C4orf34.d 586 to 691 101 to 1     Submitted on the opposite strand 101/101
(100 %)
6 diff
(94.1 %id)
BG248921 hypernephroma, cell line, Kidney C4orf34.d 589 to 1349 1 to 750       750/904
(82 %)
23 diff
(97.5 %id)
BF028524 bladder, carcinoma, cell line C4orf34.d 599 to 1234 1 to 646       646/683
(94 %)
67 diff
(90.2 %id)
BM476386 lymph, lymphoma, cell line C4orf34.d 615 to 1394 1 to 780   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 780/780
(100 %)
2 diff
(99.8 %id)
CK429972 eye, lacrimal gland C4orf34.d 631 to 1249 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BI830952 brain, medulla C4orf34.d 641 to 1341 1 to 692       692/692
(100 %)
9 diff
(98.7 %id)
TI_57177447   C4orf34.d 641 to 1341 70 to 761       692/761
(90 %)
9 diff
(98.9 %id)
BG196450   C4orf34.d 649 to 1224 1 to 574       574/796
(72 %)
30 diff
(96.3 %id)
BG192381   C4orf34.d 652 to 1390 1 to 737       737/781
(94 %)
10 diff
(98.8 %id)
BF087228 head_neck C4orf34.d 664 to 1033 390 to 25       366/393
(93 %)
0 diff
(100 %id)
CA423737 cell lines, Chondrosarcoma C4orf34.d 668 to 1389 737 to 16   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 722/722
(100 %)
1 diff
(99.9 %id)
BQ308505 breast C4orf34.d 672 to 1102 1 to 428       428/428
(100 %)
19 diff
(95.6 %id)
AI904660 breast C4orf34.d 676 to 1012 1 to 338       338/341
(99 %)
4 diff
(98.9 %id)
CA412563 Chondrosarcoma Grade II, Left Pelvis C4orf34.d 704 to 1389 703 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 685/685
(100 %)
4 diff
(99.5 %id)
BF681158 Prostate C4orf34.d 724 to 1389 1 to 651       651/821
(79 %)
26 diff
(96.9 %id)
CA503162 Human Lung Epithelial cells, lung C4orf34.d 724 to 1389 681 to 16   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 666/666
(100 %)
0 diff
(100 %id)
CB146872 Liver C4orf34.d 725 to 1283 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BE076966 breast C4orf34.d 728 to 1124 412 to 16     Submitted on the opposite strand 397/422
(94 %)
0 diff
(100 %id)
BE076972 breast C4orf34.d 728 to 1124 420 to 24     Submitted on the opposite strand 397/430
(92 %)
0 diff
(100 %id)
BE693993 breast C4orf34.d 730 to 1124 410 to 16       395/422
(93 %)
0 diff
(100 %id)
DN912185   C4orf34.d 733 to 1394 662 to 2       661/662
(99 %)
0 diff
(100 %id)
BU431404 lymph C4orf34.d 733 to 1218 1 to 486       486/486
(100 %)
4 diff
(99.2 %id)
TI_154153345   C4orf34.d 740 to 1342 80 to 680       601/601
(100 %)
6 diff
(99.1 %id)
GW493513 stomach C4orf34.d 755 to 1173 1 to 419       419/419
(100 %)
0 diff
(100 %id)
BM762934 myeloma C4orf34.d 758 to 1386 1 to 626       626/626
(100 %)
6 diff
(99.1 %id)
FN097153 breast carcinoma C4orf34.d 759 to 838 1 to 79       79/79
(100 %)
1 diff
(98.8 %id)
CA778280 Pancreas, Purified pancreatic islet C4orf34.d 763 to 1364 1 to 601   fully sequenced,   601/601
(100 %)
6 diff
(99.1 %id)
BM719627 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid C4orf34.d 785 to 1386 1 to 602   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 602/602
(100 %)
0 diff
(100 %id)
AV748388 Pituitary C4orf34.d 812 to 1173 1 to 352       352/352
(100 %)
6 diff
(98.3 %id)
BU854441 testis C4orf34.d 815 to 1390 1 to 576       576/613
(93 %)
3 diff
(99.6 %id)
FN124360 breast carcinoma C4orf34.d 829 to 942 108 to 1     Submitted on the opposite strand 108/108
(100 %)
5 diff
(95.4 %id)
BE972723 testis C4orf34.d 842 to 1392 1 to 554       554/604
(91 %)
6 diff
(99.1 %id)
FN102433 breast carcinoma C4orf34.d 845 to 932 87 to 1     Submitted on the opposite strand 87/87
(100 %)
2 diff
(97.8 %id)
BM141824 Islets of Langerhans, Pancreas C4orf34.d 851 to 1392 547 to 6       542/547
(99 %)
0 diff
(100 %id)
R45713   C4orf34.d 852 to 1158 307 to 1       307/317
(96 %)
5 diff
(98.5 %id)
BF094109 uterus_tumor C4orf34.d 856 to 1022 172 to 6       167/172
(97 %)
0 diff
(100 %id)
FN131210 breast carcinoma C4orf34.d 865 to 983 1 to 117       117/118
(99 %)
8 diff
(93.3 %id)
AV748387 Pituitary C4orf34.d 878 to 1183 1 to 296       296/297
(99 %)
7 diff
(97.7 %id)
BE644747 carcinoid, lung C4orf34.d 884 to 1390 508 to 3       506/508
(99 %)
0 diff
(100 %id)
AI377827 pooled C4orf34.d 894 to 1393 505 to 6       500/505
(99 %)
0 diff
(100 %id)
AI090059 uterus C4orf34.d 901 to 1389 489 to 1       489/489
(100 %)
0 diff
(100 %id)
BF677655 Prostate C4orf34.d 902 to 1629 1 to 718       718/877
(81 %)
29 diff
(96.7 %id)
BM795801 stomach C4orf34.d 913 to 1386 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BI491333 cochlea, ear C4orf34.d 915 to 1390 497 to 22   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 476/486
(97 %)
0 diff
(100 %id)
AW020696 cochlea, ear C4orf34.d 915 to 1333 8 to 429   fully sequenced,   422/429
(98 %)
6 diff
(98.7 %id)
AW020975 cochlea, ear C4orf34.d 915 to 1394 8 to 487   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 480/487
(98 %)
6 diff
(98.8 %id)
AW020991 cochlea, ear C4orf34.d 915 to 1394 8 to 487   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 480/487
(98 %)
6 diff
(98.8 %id)
AW022491 cochlea, ear C4orf34.d 915 to 1307 9 to 403       395/404
(97 %)
4 diff
(99.1 %id)
AW022510 cochlea, ear C4orf34.d 915 to 1370 8 to 466       459/466
(98 %)
6 diff
(98.8 %id)
AW023237 cochlea, ear C4orf34.d 915 to 1342 8 to 443       436/443
(98 %)
6 diff
(98.7 %id)
AW085702 esophagus, squamous cell carcinoma C4orf34.d 916 to 1299 384 to 1       384/384
(100 %)
0 diff
(100 %id)
DB523235 testis C4orf34.d 927 to 1386 1 to 460     Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
TI_159712590   C4orf34.d 928 to 1363 71 to 506     Submitted on the opposite strand 436/1136
(38 %)
2 diff
(99.9 %id)
CB851939 Human Lung Epithelial cells, lung C4orf34.d 928 to 1363 16 to 451     Submitted on the opposite strand 436/460
(94 %)
2 diff
(99.6 %id)
BE670260 carcinoid, lung C4orf34.d 946 to 1390 447 to 3       445/447
(99 %)
0 diff
(100 %id)
AI479648 B-cell, chronic lymphotic leukemia C4orf34.d 955 to 1398 447 to 4       444/447
(99 %)
0 diff
(100 %id)
BI491934 cochlea, ear C4orf34.d 955 to 1401 457 to 12   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 446/446
(100 %)
5 diff
(98.9 %id)
BI491950 cochlea, ear C4orf34.d 955 to 1398 443 to 1   fully sequenced, Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 443/443
(100 %)
3 diff
(99.4 %id)
BF029105 bladder, carcinoma, cell line C4orf34.d 958 to 1671 1 to 710       710/823
(86 %)
40 diff
(95.2 %id)
BQ011504 placenta C4orf34.d 962 to 1387 446 to 22       425/446
(95 %)
0 diff
(100 %id)
AI473864 follicular lymphoma, lymph node C4orf34.d 964 to 1393 435 to 6       430/435
(98 %)
0 diff
(100 %id)
BF671025 muscle (skeletal) C4orf34.d 970 to 1687 1 to 718       718/818
(87 %)
29 diff
(96.5 %id)
BX365495   C4orf34.d 977 to 1848 883 to 10       874/883
(98 %)
8 diff
(99.1 %id)
AI809733 B-cell, chronic lymphotic leukemia C4orf34.d 980 to 1400 422 to 2       421/422
(99 %)
0 diff
(100 %id)
AI273304 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus C4orf34.d 982 to 1389 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI299474 carcinoid, lung C4orf34.d 984 to 1388 405 to 1       405/405
(100 %)
0 diff
(100 %id)
AA834966   C4orf34.d 985 to 1390 409 to 3       407/409
(99 %)
0 diff
(100 %id)
DA984869 synovial membrane tissue from rheumatioidarthritis C4orf34.d 992 to 1565 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BM682918 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid C4orf34.d 997 to 1384 408 to 21   fully sequenced, Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 388/408
(95 %)
0 diff
(100 %id)
EC443919 Prostate C4orf34.d 1022 to 1151 1 to 126       126/126
(100 %)
4 diff
(96.9 %id)
AI476120 lymph node, lymphoma, follicular mixed small and largecell C4orf34.d 1027 to 1394 367 to 1       367/367
(100 %)
1 diff
(99.8 %id)
BI491670 cochlea, ear C4orf34.d 1028 to 1342 315 to 1   fully sequenced,   315/315
(100 %)
8 diff
(97.5 %id)
CB158850 Liver C4orf34.d 1039 to 1291 278 to 27   AAA Submitted on the opposite strand 252/261
(96 %)
0 diff
(100 %id)
BX454482 placenta C4orf34.d 1041 to 1883 847 to 1     Submitted on the opposite strand 847/885
(95 %)
22 diff
(97.6 %id)
DA430292 colon C4orf34.d 1049 to 1603 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA041622 bladder C4orf34.d 1051 to 1348 2 to 299   capped   298/298
(100 %)
0 diff
(100 %id)
DA362107 subthalamic nucleus C4orf34.d 1070 to 1629 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
FN056895 breast carcinoma C4orf34.d 1071 to 1198 1 to 127       127/127
(100 %)
1 diff
(99.3 %id)
CB139838 Liver C4orf34.d 1071 to 1366 1 to 296       296/296
(100 %)
0 diff
(100 %id)
DA637016 Liver C4orf34.d 1071 to 1819 2 to 755   capped   754/765
(98 %)
7 diff
(99.1 %id)
BU568987 testis C4orf34.d 1074 to 1819 1 to 749       749/822
(91 %)
14 diff
(98.3 %id)
AW612029 Kidney C4orf34.d 1101 to 1393 303 to 11   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 293/293
(100 %)
0 diff
(100 %id)
AA769315 germinal center B cell C4orf34.d 1107 to 1389 330 to 47   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 284/284
(100 %)
4 diff
(98.6 %id)
BE615527 adenocarcinoma, Pancreas C4orf34.d 1175 to 1880 1 to 702       702/702
(100 %)
8 diff
(98.9 %id)
BE615146 adenocarcinoma, Pancreas C4orf34.d 1179 to 1893 1 to 708       708/815
(86 %)
18 diff
(97.8 %id)
CD366259 Alveolar Macrophage, lung C4orf34.d 1183 to 1885 721 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 703/703
(100 %)
0 diff
(100 %id)
AI719830 aorta C4orf34.d 1217 to 1372 170 to 15       156/170
(91 %)
0 diff
(100 %id)
BG186675   C4orf34.d 1236 to 1371 135 to 1     Submitted on the opposite strand 135/135
(100 %)
3 diff
(97.8 %id)
FN139784 breast carcinoma C4orf34.d 1271 to 1375 1 to 109       109/124
(87 %)
7 diff
(94.4 %id)
CA776381 Pancreas, Purified pancreatic islet C4orf34.d 1281 to 1884 604 to 1       604/604
(100 %)
0 diff
(100 %id)
CK822412 Pancreas, Purified pancreatic islet C4orf34.d 1299 to 1807 509 to 1     Submitted on the opposite strand 509/509
(100 %)
7 diff
(98.7 %id)
BF791859 adrenal cortex carcinoma, cell line, adrenal gland C4orf34.d 1316 to 2091 1 to 772       772/895
(86 %)
43 diff
(95.2 %id)
AU155161 ovary, tumor tissue C4orf34.d 1326 to 1881 564 to 6       559/564
(99 %)
0 diff
(100 %id)
CA777993 Pancreas, Purified pancreatic islet C4orf34.d 1334 to 1885 552 to 1   fully sequenced,   552/552
(100 %)
4 diff
(99.3 %id)
CF129810 Chondrosarcoma Lung Metastasis cell lines, lung C4orf34.d 1342 to 1885 1 to 544   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 544/544
(100 %)
4 diff
(99.3 %id)
TI_154191687   C4orf34.d 1342 to 1885 51 to 594   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 544/544
(100 %)
4 diff
(99.3 %id)
BM504534 Pancreas, Purified pancreatic islet C4orf34.d 1367 to 1885 519 to 1       519/519
(100 %)
6 diff
(98.9 %id)
T74259 Liver C4orf34.d 1392 to 1887 505 to 1       505/508
(99 %)
11 diff
(97.9 %id)
AA636102 Ewing's sarcoma C4orf34.d 1403 to 1752 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AI750950 Bone, Hip C4orf34.d 1419 to 1895 477 to 1       477/477
(100 %)
2 diff
(99.6 %id)
FN048420 breast carcinoma C4orf34.d 1424 to 1532 1 to 109       109/109
(100 %)
0 diff
(100 %id)
AW073498 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma C4orf34.d 1444 to 1886 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI929410 brain, frontal lobe C4orf34.d 1449 to 1898 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI753672 bone marrow stroma C4orf34.d 1453 to 1885 458 to 26   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 433/433
(100 %)
0 diff
(100 %id)
CD104476 Pooled-Skin C4orf34.d 1455 to 1885 1 to 431   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 431/431
(100 %)
16 diff
(96.3 %id)
N22153 cochlea, ear C4orf34.d 1481 to 1887 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
AW501411 lymph C4orf34.d 1487 to 2032 1 to 546       546/546
(100 %)
5 diff
(99.1 %id)
CF143978 lymph C4orf34.d 1487 to 1835 1 to 350       350/350
(100 %)
9 diff
(97.5 %id)
TI_154156320   C4orf34.d 1494 to 2094 76 to 676       601/610
(98 %)
2 diff
(99.7 %id)
BX509398   C4orf34.d 1523 to 2158 1 to 636       636/636
(100 %)
3 diff
(99.6 %id)
BU431506 lymph C4orf34.d 1535 to 1849 315 to 1     Submitted on the opposite strand 315/497
(63 %)
5 diff
(99.0 %id)
TI_154153455   C4orf34.d 1535 to 1842 387 to 80     Submitted on the opposite strand 308/614
(50 %)
1 diff
(99.9 %id)
EC484395 Prostate C4orf34.d 1539 to 1644 21 to 122       102/122
(83 %)
6 diff
(95.1 %id)
DB513760 testis C4orf34.d 1637 to 2036 1 to 398     Submitted on the opposite strand 398/398
(100 %)
5 diff
(98.8 %id)
AW407755 lymph C4orf34.d 1683 to 2077 8 to 402       395/402
(98 %)
6 diff
(98.6 %id)
TI_154145287   C4orf34.d 1683 to 2242 89 to 643   AAA   555/771
(71 %)
24 diff
(96.9 %id)
TI_154146439   C4orf34.d 1683 to 2251 82 to 655       574/602
(95 %)
43 diff
(92.9 %id)
AI939441 brain, glioblastoma (pooled) C4orf34.d 1709 to 2206 498 to 1       498/498
(100 %)
1 diff
(99.8 %id)
BE379615 bladder, carcinoma, cell line C4orf34.d 1724 to 1810 88 to 1       88/88
(100 %)
1 diff
(98.9 %id)
DA995975 synovial membrane tissue from rheumatioidarthritis C4orf34.d 1728 to 2261 2 to 535   tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
AW504976 lymph C4orf34.d 1745 to 2197 1 to 453       453/453
(100 %)
6 diff
(98.7 %id)
TI_154161413   C4orf34.d 1750 to 2325 72 to 647       576/577
(99 %)
20 diff
(96.6 %id)
CN274884 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 C4orf34.d 1799 to 2036 1 to 238   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 238/238
(100 %)
0 diff
(100 %id)
AI418638 brain, glioblastoma (pooled) C4orf34.d 1848 to 2206 359 to 1       359/359
(100 %)
0 diff
(100 %id)
ES307441 beard hair, skin C4orf34.d 1871 to 2049 1 to 179       179/179
(100 %)
1 diff
(99.5 %id)
AL602421 human skeletal muscle C4orf34.d 1975 to 2575 1 to 601   tiling clone,   601/601
(100 %)
0 diff
(100 %id)
BG900242 cartilage C4orf34.d 2082 to 2369 399 to 111       289/330
(87 %)
0 diff
(100 %id)
BI037697 nervous_tumor C4orf34.d 2141 to 2495 356 to 2       355/356
(99 %)
0 diff
(100 %id)
BI039623 nervous_tumor C4orf34.d 2141 to 2495 356 to 2       355/356
(99 %)
0 diff
(100 %id)
DB520937 testis C4orf34.d 2270 to 2713 1 to 444     Submitted on the opposite strand 444/444
(100 %)
1 diff
(99.8 %id)
AW263314 brain, three pooled meningiomas C4orf34.d 2301 to 2721 425 to 1       425/425
(100 %)
4 diff
(99.1 %id)
AW894118 nervous_normal C4orf34.d 2326 to 2630 1 to 307       307/316
(97 %)
7 diff
(97.8 %id)
BF678280 Prostate C4orf34.d 2346 to 2945 1 to 607       607/729
(83 %)
23 diff
(96.9 %id)
CA952698 Pancreas, Purified pancreatic islet C4orf34.d 2376 to 2603 1 to 228       228/228
(100 %)
2 diff
(99.2 %id)
CV363950 lung_normal C4orf34.d 2389 to 2832 3 to 453       451/453
(99 %)
6 diff
(98.7 %id)
AW500407 lymph C4orf34.d 2406 to 2924 7 to 525       519/525
(98 %)
9 diff
(98.3 %id)
TI_154154622   C4orf34.d 2406 to 3057 79 to 729       651/651
(100 %)
13 diff
(98.1 %id)
DA642239 Liver C4orf34.d 2468 to 3059 2 to 589   tiling clone, capped   588/588
(100 %)
3 diff
(99.5 %id)
AW327242 breast, heart C4orf34.d 2522 to 2721 220 to 21   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 200/200
(100 %)
1 diff
(99.5 %id)
DB200621 trachea C4orf34.d 2569 to 3122 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
AW504585 lymph C4orf34.d 2584 to 3017 1 to 435       435/436
(99 %)
4 diff
(99.1 %id)
TI_154160793   C4orf34.d 2591 to 3148 84 to 642       559/564
(99 %)
21 diff
(96.3 %id)
EB362189 eye, lens C4orf34.d 2686 to 2782 96 to 1       96/96
(100 %)
2 diff
(98.0 %id)
DA176921 amygdala C4orf34.d 2700 to 3149 2 to 451   tiling clone, capped   450/451
(99 %)
1 diff
(99.8 %id)
H63209 liver and spleen C4orf34.d 2810 to 3186 1 to 378       378/378
(100 %)
3 diff
(99.3 %id)
T80929 liver and spleen C4orf34.d 2864 to 3216 1 to 365       365/433
(84 %)
19 diff
(95.7 %id)
BE004477 breast_normal C4orf34.d 2995 to 3370 1 to 376   tiling clone,   376/376
(100 %)
5 diff
(98.7 %id)
CX756350 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass C4orf34.d 3022 to 3311 1 to 290     Submitted on the opposite strand 290/296
(97 %)
2 diff
(99.4 %id)
AW892219 nervous_normal C4orf34.d 3081 to 3350 277 to 4       274/277
(98 %)
0 diff
(100 %id)
AK130274 Prostate C4orf34.d 3227 to 5512 1 to 2283   tiling clone, available from FLJ,   2283/2283
(100 %)
18 diff
(99.3 %id)
BG565717 Liver C4orf34.d 3541 to 3799 1 to 259   tiling clone,   259/259
(100 %)
6 diff
(97.7 %id)
AA323951 brain, cerebellum C4orf34.d 3559 to 3911 1 to 356   tiling clone,   356/356
(100 %)
5 diff
(98.6 %id)
BE869618 adenocarcinoma, colon C4orf34.d 3884 to 4511 1 to 624       624/854
(73 %)
13 diff
(98.5 %id)
BM504878 Pancreas, Purified pancreatic islet C4orf34.d 3886 to 4326 37 to 477       441/477
(92 %)
1 diff
(99.8 %id)
BP395454 pancreatic islet C4orf34.d 3886 to 4443 1 to 558     Submitted on the opposite strand 558/558
(100 %)
2 diff
(99.7 %id)
AI824013 2 pooled tumors (clear cell type), Kidney C4orf34.d 3900 to 4439 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AI589533 anaplastic oligodendroglioma, brain C4orf34.d 3901 to 4439 539 to 1       539/539
(100 %)
1 diff
(99.9 %id)
BM504554 Pancreas, Purified pancreatic islet C4orf34.d 3910 to 4438 529 to 1       529/529
(100 %)
1 diff
(99.9 %id)
AA779799   C4orf34.d 3953 to 4439 487 to 1       487/487
(100 %)
7 diff
(98.6 %id)
BF678806 Prostate C4orf34.d 3961 to 4510 1 to 549       549/586
(93 %)
20 diff
(96.6 %id)
BE886324 leiomyosarcoma, uterus C4orf34.d 3966 to 4521 1 to 555       555/836
(66 %)
16 diff
(98.1 %id)
AI056974 liver and spleen C4orf34.d 3977 to 4439 463 to 1       463/463
(100 %)
1 diff
(99.8 %id)
AW967370   C4orf34.d 3985 to 4532 1 to 549       549/617
(88 %)
6 diff
(99.1 %id)
AI333109 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus C4orf34.d 3985 to 4439 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AI719455 colon C4orf34.d 3991 to 4439 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
AI307170 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus C4orf34.d 3993 to 4439 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
AA074109 pineal gland C4orf34.d 4006 to 4440 438 to 1       438/439
(99 %)
5 diff
(98.9 %id)
DA831779 placenta C4orf34.d 4015 to 4757 2 to 748   capped   747/842
(88 %)
10 diff
(98.9 %id)
N66857 liver and spleen C4orf34.d 4017 to 4439 426 to 2       425/426
(99 %)
0 diff
(100 %id)
CR591173 placenta C4orf34.d 4019 to 5511 1 to 1493   tiling clone,   1493/1493
(100 %)
0 diff
(100 %id)
BX439530 placenta C4orf34.d 4019 to 4877 1 to 862       862/862
(100 %)
5 diff
(99.5 %id)
N46180 melanocyte C4orf34.d 4020 to 4448 1 to 429     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 429/430
(99 %)
3 diff
(99.4 %id)
H63123 liver and spleen C4orf34.d 4051 to 4223 173 to 1       173/173
(100 %)
0 diff
(100 %id)
CD558787 White Matter C4orf34.d 4058 to 4621 15 to 580       566/1048
(54 %)
6 diff
(99.5 %id)
BF003078 Prostate C4orf34.d 4059 to 4439 381 to 1       381/381
(100 %)
2 diff
(99.5 %id)
DA296041 hippocampus C4orf34.d 4138 to 4693 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
T80853 liver and spleen C4orf34.d 4139 to 4431 294 to 1       294/295
(99 %)
4 diff
(98.7 %id)
AW189610 serous papillary carcinoma, high grade, 2pooled tumors, uterus C4orf34.d 4226 to 4439 214 to 1       214/214
(100 %)
0 diff
(100 %id)
CA422569 cell lines, Chondrosarcoma C4orf34.d 4236 to 4890 673 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 655/655
(100 %)
2 diff
(99.7 %id)
DA603209   C4orf34.d 4263 to 4814 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB335098 synovial membrane tissue from rheumatioidarthritis C4orf34.d 4312 to 4890 581 to 1       581/581
(100 %)
1 diff
(99.9 %id)
DA077503 cerebellum C4orf34.d 4314 to 4876 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
EL955036 eyeball C4orf34.d 4358 to 4809 1 to 452       452/452
(100 %)
5 diff
(98.9 %id)
BM751175 Ascites, stomach C4orf34.d 4443 to 4670 1 to 229       229/229
(100 %)
9 diff
(96.1 %id)
AW518882 adenocarcinoma, Pancreas C4orf34.d 4451 to 4892 442 to 1       442/442
(100 %)
0 diff
(100 %id)
BU628037 Bone, Enchondroma cell line C4orf34.d 4452 to 4890 11 to 449   AAA Submitted on the opposite strand 439/449
(97 %)
6 diff
(98.7 %id)
W31756 parathyroid gland, parathyroid tumor C4orf34.d 4460 to 4536 1 to 79       79/80
(98 %)
3 diff
(96.3 %id)
T10579   C4orf34.d 4502 to 4750 1 to 250       250/250
(100 %)
3 diff
(98.8 %id)
AW148964 Kidney, renal cell tumor C4orf34.d 4502 to 4890 419 to 30   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 390/390
(100 %)
8 diff
(98.0 %id)
BG927041 cartilage C4orf34.d 4510 to 4844 86 to 420       335/352
(95 %)
6 diff
(98.3 %id)
BF970107 adrenal cortex carcinoma, cell line, adrenal gland C4orf34.d 4568 to 4890 1 to 323   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 323/323
(100 %)
0 diff
(100 %id)
BX409945 placenta C4orf34.d 4584 to 5511 1 to 928       928/929
(99 %)
16 diff
(98.3 %id)
AW631267 2 pooled high-grade transitional celltumors, genitourinary tract C4orf34.d 4602 to 5040 1 to 439       439/439
(100 %)
0 diff
(100 %id)
AA480974 germinal center B cell C4orf34.d 4625 to 4891 1 to 267     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 267/267
(100 %)
1 diff
(99.7 %id)
BE048305 brain, tumor, 5 pooled (see description) C4orf34.d 4648 to 5055 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
TI_154102478   C4orf34.d 4764 to 5515 827 to 80   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 748/791
(94 %)
18 diff
(97.8 %id)
N76712 multiple sclerosis lesions C4orf34.d 4793 to 5101 1 to 308   fully sequenced,   308/308
(100 %)
8 diff
(97.5 %id)
BX107297 multiple sclerosis lesions C4orf34.d 4798 to 5515 1 to 717   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 717/717
(100 %)
2 diff
(99.8 %id)
AA130098 uterus C4orf34.d 4861 to 5284 1 to 425   fully sequenced,   425/425
(100 %)
4 diff
(99.1 %id)
CA313020 Human Lung Epithelial cells, lung C4orf34.d 4877 to 5509 18 to 651   AAA Submitted on the opposite strand 634/651
(97 %)
2 diff
(99.7 %id)
CA312953 Human Lung Epithelial cells, lung C4orf34.d 4877 to 5509 18 to 651   AAA Submitted on the opposite strand 634/651
(97 %)
2 diff
(99.7 %id)
AI356626 brain, glioblastoma (pooled) C4orf34.d 4899 to 5283 385 to 1       385/385
(100 %)
0 diff
(100 %id)
BQ723422 sympathetic trunk C4orf34.d 4911 to 5515 1 to 606       606/997
(60 %)
4 diff
(99.6 %id)
BQ719703 sympathetic trunk C4orf34.d 4911 to 5520 1 to 611       611/995
(61 %)
2 diff
(99.8 %id)
AA888649 metastatic prostate bone lesion C4orf34.d 4925 to 5216 1 to 292       292/292
(100 %)
2 diff
(99.4 %id)
AI810669 Prostate C4orf34.d 4925 to 5516 592 to 1       592/592
(100 %)
2 diff
(99.7 %id)
FN146311 breast carcinoma C4orf34.d 4926 to 4988 1 to 63       63/63
(100 %)
0 diff
(100 %id)
CA445553 Chondrosarcoma, Left Pubic Bone C4orf34.d 4935 to 5515 596 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 581/581
(100 %)
3 diff
(99.5 %id)
BM740097 Ascites, stomach C4orf34.d 4940 to 5512 1 to 572   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 572/572
(100 %)
3 diff
(99.5 %id)
BF438704 brain, glioblastoma (pooled) C4orf34.d 4955 to 5512 558 to 1       558/558
(100 %)
1 diff
(99.9 %id)
BP418707 small intestine C4orf34.d 4963 to 5419 1 to 457     Submitted on the opposite strand 457/457
(100 %)
3 diff
(99.4 %id)
CA393681 eye, RPE/choroid C4orf34.d 4972 to 5487 1 to 516       516/516
(100 %)
0 diff
(100 %id)
DB321187 Liver C4orf34.d 4983 to 5515 532 to 1       532/534
(99 %)
13 diff
(97.6 %id)
FN091983 breast carcinoma C4orf34.d 4985 to 5105 1 to 125       125/125
(100 %)
3 diff
(97.6 %id)
BG055264 carcinoid, lung C4orf34.d 4993 to 5514 526 to 3       524/526
(99 %)
0 diff
(100 %id)
AI400843 Prostate C4orf34.d 5006 to 5515 510 to 1       510/510
(100 %)
0 diff
(100 %id)
AW295092   C4orf34.d 5022 to 5422 1 to 401     Submitted on the opposite strand 401/401
(100 %)
13 diff
(96.8 %id)
AI435370 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus C4orf34.d 5027 to 5512 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
AI421516 brain, glioblastoma (pooled) C4orf34.d 5029 to 5512 484 to 1       484/484
(100 %)
3 diff
(99.4 %id)
AI126517 uterus C4orf34.d 5037 to 5516 484 to 5       480/484
(99 %)
0 diff
(100 %id)
AA480975 germinal center B cell C4orf34.d 5041 to 5515 493 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 475/475
(100 %)
0 diff
(100 %id)
CA952449 Pancreas, Purified pancreatic islet C4orf34.d 5043 to 5515 473 to 1       473/473
(100 %)
0 diff
(100 %id)
BQ228409 epithelioid carcinoma, Pancreas C4orf34.d 5057 to 5515 1 to 458   AAA   458/472
(97 %)
5 diff
(99.0 %id)
AI681169 carcinoid, lung C4orf34.d 5060 to 5512 453 to 1       453/453
(100 %)
1 diff
(99.8 %id)
N52885 multiple sclerosis lesions C4orf34.d 5077 to 5515 449 to 1       449/453
(99 %)
12 diff
(97.4 %id)
DB377606 placenta C4orf34.d 5078 to 5515 440 to 2       439/442
(99 %)
0 diff
(100 %id)
N59244 multiple sclerosis lesions C4orf34.d 5087 to 5515 432 to 1   fully sequenced,   432/432
(100 %)
11 diff
(97.5 %id)
BG621054 placenta C4orf34.d 5103 to 5508 1 to 406   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 406/406
(100 %)
1 diff
(99.8 %id)
W16830 parathyroid gland, parathyroid tumor C4orf34.d 5118 to 5517 416 to 1       416/416
(100 %)
17 diff
(96.0 %id)
CB144676 Liver C4orf34.d 5125 to 5648 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
AI381249   C4orf34.d 5136 to 5467 340 to 7       334/340
(98 %)
0 diff
(100 %id)
AI765570 2 pooled tumors (clear cell type), Kidney C4orf34.d 5140 to 5482 388 to 46   AAA   343/370
(92 %)
0 diff
(100 %id)
BM126870 Islets of Langerhans, Pancreas C4orf34.d 5144 to 5512 1 to 369   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 369/369
(100 %)
1 diff
(99.8 %id)
AI811833 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors C4orf34.d 5151 to 5512 379 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 362/362
(100 %)
1 diff
(99.8 %id)
AI955382 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors C4orf34.d 5151 to 5515 385 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 367/367
(100 %)
2 diff
(99.5 %id)
BE244951 leukopheresis C4orf34.d 5155 to 5515 361 to 1       361/362
(99 %)
4 diff
(98.9 %id)
AI356786 brain, glioblastoma (pooled) C4orf34.d 5188 to 5514 329 to 3       327/329
(99 %)
0 diff
(100 %id)
CD239151 Pituitary C4orf34.d 5193 to 5515 1 to 323   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 323/323
(100 %)
1 diff
(99.7 %id)
AA650144   C4orf34.d 5199 to 5516 324 to 7       318/327
(97 %)
0 diff
(100 %id)
AA848096 germinal center B cell C4orf34.d 5199 to 5516 329 to 12       318/329
(96 %)
0 diff
(100 %id)
N36904 melanocyte C4orf34.d 5214 to 5515 319 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 304/306
(99 %)
4 diff
(98.7 %id)
AA564993 adrenal adenoma, adrenal gland C4orf34.d 5233 to 5516 285 to 2       284/285
(99 %)
0 diff
(100 %id)
FN146759 breast carcinoma C4orf34.d 5250 to 5363 115 to 1     Submitted on the opposite strand 115/115
(100 %)
2 diff
(98.3 %id)
AA844120 parathyroid gland, parathyroid tumor C4orf34.d 5252 to 5512 281 to 21   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 261/261
(100 %)
0 diff
(100 %id)
BM692266 eye, human retina C4orf34.d 5253 to 5515 1 to 263   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 263/263
(100 %)
1 diff
(99.7 %id)
AA130099 uterus C4orf34.d 5254 to 5493 240 to 1   fully sequenced,   240/240
(100 %)
1 diff
(99.6 %id)
D62190   C4orf34.d 5266 to 5476 213 to 3     Submitted on the opposite strand 211/213
(99 %)
0 diff
(100 %id)
N64161 cochlea, ear C4orf34.d 5275 to 5516 248 to 1       248/248
(100 %)
9 diff
(96.4 %id)
AA564982 adrenal adenoma, adrenal gland C4orf34.d 5284 to 5516 234 to 2       233/234
(99 %)
0 diff
(100 %id)
FN112077 breast carcinoma C4orf34.d 5333 to 5406 1 to 74       74/75
(98 %)
3 diff
(96.0 %id)
BM673532 eye, human retina C4orf34.d 5388 to 5481 94 to 1   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 94/94
(100 %)
0 diff
(100 %id)
AW662945 2 pooled high-grade transitional celltumors, genitourinary tract C4orf34.d 5468 to 5793 1 to 326   tiling clone,   326/326
(100 %)
10 diff
(97.0 %id)
BX116484 breast C4orf34.d 5634 to 6274 1 to 641   tiling clone,   641/641
(100 %)
1 diff
(99.9 %id)
H45304 breast C4orf34.d 5634 to 6029 1 to 400   fully sequenced,   400/400
(100 %)
13 diff
(96.8 %id)
FN084148 breast carcinoma C4orf34.d 5732 to 5841 110 to 1     Submitted on the opposite strand 110/110
(100 %)
0 diff
(100 %id)
DB307823 hippocampus C4orf34.d 5736 to 6247 515 to 1       515/515
(100 %)
5 diff
(99.1 %id)
BJ997373 neuroblastoma C4orf34.d 5738 to 6248 1 to 509       509/511
(99 %)
9 diff
(98.3 %id)
AI743027 pooled C4orf34.d 5748 to 6248 503 to 3       501/503
(99 %)
0 diff
(100 %id)
AA884714 pooled C4orf34.d 5763 to 6218 1 to 456     Submitted on the opposite strand 456/456
(100 %)
1 diff
(99.8 %id)
AW468911 pooled C4orf34.d 5771 to 6142 1 to 375     Submitted on the opposite strand 375/375
(100 %)
4 diff
(99.0 %id)
AW304053 pooled C4orf34.d 5777 to 6138 1 to 362     Submitted on the opposite strand 362/362
(100 %)
2 diff
(99.5 %id)
H45244 breast C4orf34.d 6025 to 6461 448 to 13   tiling clone, fully sequenced,   436/448
(97 %)
0 diff
(100 %id)
AA095600   C4orf34.d 6322 to 6583 261 to 1   tiling clone, Submitted on the opposite strand 261/261
(100 %)
3 diff
(98.9 %id)
BU568945 testis C4orf34.e 1 to 726 1 to 742 exact tiling clone,   742/851
(87 %)
21 diff
(97.6 %id)
BF028406 bladder, carcinoma, cell line C4orf34.f 1 to 608 1 to 598 V32S W33G A34R D35I L36* tiling clone,   598/879
(68 %)
21 diff
(97.7 %id)
BG220387   C4orf34.g 1 to 775 1 to 773 exact tiling clone,   773/775
(99 %)
8 diff
(99.0 %id)
DA242073 brain C4orf34.h 1 to 577 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
CA390652 eye, RPE/choroid C4orf34.h 42 to 537 1 to 496       496/496
(100 %)
2 diff
(99.6 %id)
BE973684 Prostate C4orf34.h 57 to 736 1 to 676   tiling clone,   676/808
(83 %)
18 diff
(97.8 %id)
BG106303 lymph, lymphoma, cell line C4orf34.i 1 to 680 1 to 683 Q27K T28R N29T E30K D31M ... tiling clone,   683/965
(70 %)
7 diff
(99.3 %id)
CR742245   C4orf34.j-u 1 to 528 1 to 529 V3X tiling clone,   529/529
(100 %)
2 diff
(99.7 %id)
AW864503 stomach_normal C4orf34.j-u 234 to 602 369 to 1 K18N Q22L Q23L K24* tiling clone,   369/383
(96 %)
6 diff
(98.5 %id)
AA229362   C4orf34.k-u 1 to 354 33 to 387 L11H Y12I K13* tiling clone,   355/387
(91 %)
6 diff
(98.5 %id)
DA557510   C4orf34.l 1 to 349 2 to 352 exact tiling clone, capped   351/351
(100 %)
12 diff
(96.6 %id)
AA654811   C4orf34.m-u 1 to 232 1 to 232 V2D tiling clone,   232/239
(97 %)
6 diff
(97.5 %id)
AA640387   C4orf34.m-u 2 to 218 1 to 217 V2D F12C tiling clone, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 217/217
(100 %)
6 diff
(97.3 %id)
AI821135   C4orf34.m-u 8 to 218 256 to 46   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 211/225
(93 %)
0 diff
(100 %id)
AI821878   C4orf34.m-u 8 to 218 8 to 218   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 211/218
(96 %)
6 diff
(97.3 %id)
AA635452   C4orf34.m-u 8 to 218 38 to 248   tiling clone, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 211/248
(85 %)
6 diff
(97.6 %id)
AA657358   C4orf34.m-u 11 to 218 1 to 207   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 207/207
(100 %)
1 diff
(99.6 %id)
FN175691 breast carcinoma C4orf34.n-u 1 to 114 1 to 117 E10V V11R A12* tiling clone,   117/121
(96 %)
6 diff
(95.1 %id)
BU675504 lung, Primary Lung Epithelial Cells Gene C4orf34, variant not shown       AAA This clone was ignored    
AV682863 hepatocellular carcinoma Gene C4orf34, variant not shown         This clone was ignored    
BE708517 head_neck Gene C4orf34, variant not shown         This clone was ignored    
BE243931 leukopheresis Gene C4orf34, variant not shown              
BE245591 leukopheresis Gene C4orf34, variant not shown              
BU624658 cell lines, Enchondroma Gene C4orf34, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BQ776197 Bone, Human Chondrosarcoma Cell Line Gene C4orf34, variant not shown       AAA This clone was ignored    
BX412387 placenta Gene C4orf34, variant not shown         This clone was ignored    
AV747814 Pituitary Gene C4orf34, variant not shown         Suspected internal deletion, this clone was ignored    
BF743172 breast Gene C4orf34, variant not shown         This clone was ignored    
DB457744 testis Gene C4orf34, variant not shown         This clone was ignored    
EB386496 eye, optic nerve Gene C4orf34, variant not shown         Suspected internal deletion, this clone was ignored    
CN277953 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 Gene C4orf34, variant not shown         This clone was ignored    
DB319321 lung Gene C4orf34, variant not shown         Suspected internal deletion, this clone was ignored    
DA583953 lung Gene C4orf34, variant not shown       capped Suspected internal deletion, this clone was ignored    
AK307146 hippocampus Gene C4orf34, variant not shown         This clone was ignored    
BX116556 liver and spleen Gene C4orf34, variant not shown         Suspected internal deletion, this clone was ignored    
DC334864 hippocampus Gene C4orf34, variant not shown         This clone was ignored    
AI433952 adenocarcinoma, Pancreas Gene C4orf34, variant not shown       AAA This clone was ignored    
BG176850 lymph, lymphoma, cell line Gene C4orf34, variant not shown         This clone was ignored    
BG169294 hypernephroma, cell line, Kidney Gene C4orf34, variant not shown         Suspected internal deletion, this clone was ignored    
BG501720 embryonal carcinoma, testis Gene C4orf34, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BG566996 Liver Gene C4orf34, variant not shown         Suspected internal deletion, this clone was ignored    
CB215910 normal endometrium, late proliferativephase, cycle day 13, uterus Gene C4orf34, variant not shown         This clone was ignored    
CA867943 Pancreas, Purified pancreatic islet Gene C4orf34, variant not shown       fully sequenced, This clone was ignored    
CA943671 Pancreas, Purified pancreatic islet Gene C4orf34, variant not shown       fully sequenced, This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k-u, .l, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI